| Literature DB >> 36175666 |
K Mellert1, C Seeling1,2, P Möller1, T F E Barth3.
Abstract
Chordomas are rare malignant tumors of the axial skeleton with notochordal differentiation. From a morphological point of view, chordomas display a broad spectrum ranging from the classical, conventional form not otherwise specified (NOS) to forms with hepatoid or renal carcinoma-like differentiation or even poorly or dedifferentiated variants. The detection of brachyury is highly characteristic, though not exclusive. The morphological differential diagnosis from a benign notochordal tumor (BNCT) requires integration of imaging since BNCT is limited to the vertebral bodies and is not osteolytic. Targeted therapy is a current research focus and cell lines as in vitro models are a precondition for the establishment and validation of this approach.Entities:
Keywords: Cell lines; Chordomas; Immunohistology; Morphology; Targeted therapy
Year: 2022 PMID: 36175666 DOI: 10.1007/s00292-022-01118-9
Source DB: PubMed Journal: Pathologie (Heidelb) ISSN: 2731-7188